SU2C announces three research teams to study gastroesophageal cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Stand Up To Cancer has announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Most cancer genome studies have focused on mutations in the tumor itself and how such gene variants allow a tumor to grow unchecked. A study led by researchers at Washington University School of Medicine in St. Louis takes a deep dive into inherited cancer mutations measured in a healthy blood sample and reports how those mutations might take a toll on the body’s cells starting at birth, perhaps predisposing a person to develop cancers at various stages of life.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login